Pharmaceutical composition containing PSYLLIUM FIBERS and
a LIPASE INHIBITOR. Efficacy in obesity, lipid lowering
and Type II diabetes. Prescription product which in combination
with psyllium reduces the side effect profile seen with
Xenical (orlistat). Initial discussions with FDA have indicated
that OTC could be a strong possibility for this powdered
formulation which can be flavored and mixed with water.
Composition and method of use in LOWERING CHOLESTEROL, TRIGLYCERIDES;
CONTAINS PSYLLIUM, GUGGUL, CHROMIUM PICNOLATE, BETA-SITOSTEROL
AND OTHER NATURAL INGREDIENTS. Also helps in weight management
and diabetes control in type II patients. Has a appetite
reduction effect. No side effects; FDA claim for cholesterol
lowering fully applicable.